These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20732173)

  • 1. Effects of the neurotoxin ethylcholine mustard aziridinium in rat brain reaggregate cultures.
    Pillar AM; Jones HB; Dunnage JE; Atterwill CK; Prince AK
    Toxicol In Vitro; 1993 Jan; 7(1):69-80. PubMed ID: 20732173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nerve growth factor and thyrotropin releasing hormone on cholinergic neurones in developing rat brain reaggregate cultures lesioned with ethylcholine mustard aziridinium.
    Atterwill CK; Collins P; Meakin J; Pillar AM; Prince AK
    Biochem Pharmacol; 1989 May; 38(10):1631-8. PubMed ID: 2499340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity in vitro: Model systems and practical applications. Comparative studies with the cholinergic neurotoxin in primary brain cultures and in rabbit retina in vivo.
    Atterwill CK
    Toxicol In Vitro; 1990; 4(4-5):346-55. PubMed ID: 20702192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurotoxicity of ethylcholine mustard aziridinium (ECMA) in rat brain reaggregate cultures.
    Pillar AM; Prince AK; Atterwill CK
    Toxicology; 1988 Apr; 49(1):115-9. PubMed ID: 2836967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain reaggregate cultures in neurotoxicological investigations: adaptational and neuroregenerative processes following lesions.
    Atterwill CK
    Mol Toxicol; 1987-1988 Fall; 1(4):489-502. PubMed ID: 3509699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological assessment of ethyl choline mustard aziridinium-induced neurotoxicity in rat brain reaggregate cultures.
    Jones HB; Pillar AM; Prince AK
    Acta Neuropathol; 1993; 86(2):154-62. PubMed ID: 8213070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose- and time-dependent hippocampal cholinergic lesions induced by ethylcholine mustard aziridinium ion: effects of nerve growth factor, GM1 ganglioside, and vitamin E.
    Johnson GV; Simonato M; Jope RS
    Neurochem Res; 1988 Aug; 13(8):685-92. PubMed ID: 3173620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve growth factor (NGF) receptors on mast cells: effects of the cholinergic neurotoxin ethylcholine mustard aziridinium ion (ECMA).
    Johnston HB; Atterwill CK
    Neurotoxicology; 1992; 13(1):155-9. PubMed ID: 1380683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of irreversible inhibition of choline transport in synaptosomes by ethylcholine mustard aziridinium.
    Curti D; Marchbanks RM
    J Membr Biol; 1984; 82(3):259-68. PubMed ID: 6549400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is ethylcholine mustard aziridinium ion a specific cholinergic neurotoxin?
    McGurk SR; Hartgraves SL; Kelly PH; Gordon MN; Butcher LL
    Neuroscience; 1987 Jul; 22(1):215-24. PubMed ID: 3627443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-specific effects of the putative cholinergic neurotoxin ethylcholine mustard aziridinium ion in the rat brain examined by autoradiography, immunocytochemistry and gel electrophoresis.
    Allen YS; Marchbanks RM; Sinden JD
    Neurosci Lett; 1988 Dec; 95(1-3):69-74. PubMed ID: 2465512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of ethylcholine mustard aziridinium as an irreversible inhibitor of choline transport in cholinergic and noncholinergic tissue.
    Uney JB; Marchbanks RM
    J Neurochem; 1987 Jun; 48(6):1673-6. PubMed ID: 3572397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic amacrine cells are not required for the progression and atropine-mediated suppression of form-deprivation myopia.
    Fischer AJ; Miethke P; Morgan IG; Stell WK
    Brain Res; 1998 May; 794(1):48-60. PubMed ID: 9630509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic but not GABAergic neuronal markers are decreased in primary neuronal cultures treated with choline mustard.
    Baskey JC; Colhoun EH; Rylett RJ
    Brain Res; 1990 Jun; 519(1-2):209-16. PubMed ID: 2397407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
    Vickroy TW; Watson M; Leventer SM; Roeske WR; Hanin I; Yamamura HI
    J Pharmacol Exp Ther; 1985 Dec; 235(3):577-82. PubMed ID: 3841155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the cholinergic neurotoxin ECMA on neural function in brain reaggregate cultures.
    Pillar AM; Prince AK; Atterwill CK
    Arch Toxicol Suppl; 1987; 11():243-6. PubMed ID: 3477176
    [No Abstract]   [Full Text] [Related]  

  • 17. Models for the in vitro assessment of neurotoxicity in the nervous system in relation to xenobiotic and neurotrophic factor-mediated events.
    Atterwill CK; Johnston H; Thomas SM
    Neurotoxicology; 1992; 13(1):39-53. PubMed ID: 1508434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nitric oxide in the ethylcholine aziridinium model of delayed apoptotic neurodegeneration in vivo and in vitro.
    Lautenschlager M; Onufriev MV; Gulyaeva NV; Harms C; Freyer D; Sehmsdorf U; Ruscher K; Moiseeva YV; Arnswald A; Victorov I; Dirnagl U; Weber JR; Hörtnagl H
    Neuroscience; 2000; 97(2):383-93. PubMed ID: 10799770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct cytotoxicity of ethylcholine mustard aziridinium in cerebral microvascular endothelial cells.
    Gómez C; Martín C; Galea E; Estrada C
    J Neurochem; 1993 Apr; 60(4):1534-9. PubMed ID: 8455040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of markers for cholinergic neurones in re-aggregate cultures of foetal rat whole brain in serum-containing and serum-free media: effects of triiodothyronine (T3).
    Atterwill CK; Kingsbury A; Nicholls J; Prince A
    Br J Pharmacol; 1984 Sep; 83(1):89-102. PubMed ID: 6487898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.